Atlas Trials

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

Clinical trial NCT07643012 · RECRUITING

Trial details

NCT number
NCT07643012
Sponsor
Rutgers, The State University of New Jersey
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2026-06-09
Primary completion
2029-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.